Skip to main content
. Author manuscript; available in PMC: 2022 Jul 9.
Published in final edited form as: ACS Appl Mater Interfaces. 2018 Feb 22;10(9):7697–7703. doi: 10.1021/acsami.7b19503

Figure 2.

Figure 2.

Intratumoral Injection of H-DAPPs in vivo. (a) Tumor volume progression over time. Treatment occurred on Day 0. Error bars are standard deviation. * denotes a significance p < 0.05. (b) Kaplan−Meier survival curve. ** denotes a significance of p < 0.01 with respect to all other groups. (c) Fluorescent images taken on IVIS of one individual mouse treated with H-DAPPs only (no NIR). (d) Representative photograph and fluorescence image of organs from an animal treated with intratumoral H-DAPPs only (no NIR). Organs top row: lungs, liver, spleen. Organs bottom row: kidneys, heart, tumor. Scale bar is 2 cm.